518 results on '"De Ponti, Fabrizio"'
Search Results
2. Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
3. Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
4. Enhancing therapeutic reasoning: key insights and recommendations for education in prescribing
5. Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
6. Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project
7. Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
8. Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”
9. µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients.
10. Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants
11. Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
12. Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems
13. Drug Interactions with Contraceptives
14. Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System
15. Teaching resources for the European Open Platform for Prescribing Education (EurOP2E)—a nominal group technique study
16. Chapter Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety
17. The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely
18. Antipsychotics and Drug-Induced Liver Injury: Toward Minimum Requirements in Reporting Pharmacovigilance Studies
19. Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems
20. The European List of Key Medicines for Medical Education: A Modified Delphi Study
21. Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
22. Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies
23. Implementing Clinical Case Discussions to Enhance Clinical Reasoning Skills: A Pilot Study in an Italian Medical School.
24. Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review
25. Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
26. Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis
27. Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
28. Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
29. Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system
30. Using artificial intelligence to create diverse and inclusive medical case vignettes for education
31. Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
32. Serotonin Modulation of Gastrointestinal Motility
33. Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis
34. Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews
35. Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective
36. Using artificial intelligence to create diverse and inclusive medical case vignettes for education.
37. Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety
38. Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice
39. Educational value of international and intercultural differences in prescribing:the international and interprofessional student-run clinic project
40. A Clinical Pharmacology and Therapeutics Teacher's Guide to Race-Based Medicine, Inclusivity, and Diversity
41. Appropriateness of Proton Pump Inhibitor prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy
42. Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders
43. Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution
44. Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study
45. Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the Fda Adverse Event Reporting System
46. Nerve Fiber Outgrowth Is Increased in the Intestinal Mucosa of Patients With Irritable Bowel Syndrome
47. Antipsychotics and Drug-Induced Liver Injury
48. ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations
49. Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping
50. Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.